2024-09-03 2025-09-30 2025-09-30 false 15932434 MB THERAPY LTD 86900Other human health activities iso4217:GBP xbrli:pure 159324342024-09-03 159324342025-09-30 159324342024-09-03 2025-09-30 15932434bus:Micro-entities2024-09-03 2025-09-30 15932434bus:AuditExempt-NoAccountantsReport2024-09-03 2025-09-30 15932434bus:FullAccounts2024-09-03 2025-09-30 15932434core:WithinOneYear2025-09-30 15932434core:AfterOneYear2025-09-30 15932434core:WithinOneYear2024-09-03 2025-09-30 15932434core:AfterOneYear2024-09-03 2025-09-30 15932434core:CurrentFinancialInstruments2025-09-30 15932434core:Non-currentFinancialInstruments2025-09-30 15932434core:CurrentFinancialInstruments2024-09-03 2025-09-30 15932434core:Non-currentFinancialInstruments2024-09-03 2025-09-30 15932434core:LandBuildings2024-09-03 2025-09-30 15932434core:FurnitureFittings2024-09-03 2025-09-30 15932434core:OfficeEquipment2024-09-03 2025-09-30 15932434core:Vehicles2024-09-03 2025-09-30 15932434core:PlantMachinery2024-09-03 2025-09-30 15932434core:OtherPropertyPlantEquipment2024-09-03 2025-09-30 15932434core:LandBuildings2025-09-30 15932434core:PlantMachinery2025-09-30 15932434core:Vehicles2025-09-30 15932434core:FurnitureFittings2025-09-30 15932434core:OfficeEquipment2025-09-30 15932434core:OtherPropertyPlantEquipment2025-09-30 15932434core:Right-of-useAssets2024-09-03 2025-09-30 15932434core:Right-of-useAssets2025-09-30 15932434core:Goodwill2024-09-03 2025-09-30 15932434core:PatentsTrademarksLicencesConcessionsSimilar2024-09-03 2025-09-30 15932434core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-09-03 2025-09-30 15932434core:OtherResidualIntangibleAssets2024-09-03 2025-09-30 15932434core:Goodwill2025-09-30 15932434core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-09-30 15932434core:PatentsTrademarksLicencesConcessionsSimilar2025-09-30 15932434core:OtherResidualIntangibleAssets2025-09-30 15932434dpl:CostSales2024-09-03 2025-09-30 15932434dpl:AdministrativeExpenses2024-09-03 2025-09-30 15932434dpl:DistributionCosts2024-09-03 2025-09-3015932434bus:Director12024-09-03 2025-09-3015932434bus:PrivateLimitedCompanyLtd2024-09-03 2025-09-30
MB THERAPY LTD
Unaudited Financial Statements
for the period ended 30 September 2025
Company registration number 15932434
(England and Wales)

Company Information

For the period 3 September 2024 to 30 September 2025
Director Brooks, Maria Lesley

Registered office Dyrham Lodge
16 Clifton Park
Bristol
BS8 3BY

Registered number 15932434

Accountant Warp Ledger Solutions Ltd

Statement of Financial Position

As at 30 September 2025
2025
£
£
Fixed assets
227
Current assets
5,071
Creditors amounts falling due within one year
41,115
Net current assets (liabilities)
46,186
Total assets less current liabilities
46,413
Creditors amounts falling due after one year
(2,730)
Net assets (liabilities)
43,683
Capital and reserves
43,683

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 1.
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors on 22 May 2026 and are signed on its behalf by:

Brooks, Maria Lesley
Brooks, Maria Lesley
Director

Company registration number 15932434